A study demonstrated that biomarkers for neurodegeneration such as neurofilament light chain protein (NFL), tau proteins, and glial fibrillary acidic protein (GFAP) are increased in the cerebrospinal fluid of COVID-19 patients by 63%, 37%, and 16%, respectively [97]. This evidence concerns the gene MAPT and COVID-19.